GIM
ABBV icon

Goelzer Investment Management’s AbbVie ABBV Stock Holding History

Goelzer Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Sell
62,744
-2,378
-4% -$512K 0.69% 20
2026
Q1 		$14.2M Buy
65,122
+2,583
+4% +$573K 0.69% 23
2025
Q4 		$14.3M Buy
62,539
+1,858
+3% +$423K 0.66% 20
2025
Q3 		$14M Buy
60,681
+10,354
+21% +$2.11M 0.74% 19
2025
Q2 		$9.34M Sell
50,327
-432
-0.9% -$80.3K 0.51% 37
2025
Q1 		$10.6M Sell
50,759
-853
-2% -$166K 0.62% 27
2024
Q4 		$9.17M Sell
51,612
-1,035
-2% -$190K 0.53% 34
2024
Q3 		$10.4M Sell
52,647
-326
-0.6% -$60.8K 0.57% 31
2024
Q2 		$9.09M Sell
52,973
-939
-2% -$156K 0.51% 35
2024
Q1 		$9.82M Buy
53,912
+562
+1% +$96.9K 0.56% 30
2023
Q4 		$8.27M Sell
53,350
-436
-0.8% -$63.6K 0.53% 39
2023
Q3 		$8.02M Sell
53,786
-1,464
-3% -$215K 0.56% 36
2023
Q2 		$7.44M Buy
55,250
+40
+0.1% +$5.87K 0.63% 45
2023
Q1 		$8.8M Buy
55,210
+5,397
+11% +$825K 0.76% 34
2022
Q4 		$8.05M Buy
49,813
+1,013
+2% +$155K 0.69% 38
2022
Q3 		$6.55M Buy
48,800
+935
+2% +$134K 0.65% 41
2022
Q2 		$7.33M Buy
47,865
+2,926
+7% +$447K 0.71% 37
2022
Q1 		$7.29M Sell
44,939
-234
-0.5% -$34K 0.63% 48
2021
Q4 		$6.12M Buy
45,173
+599
+1% +$70.8K 0.5% 61
2021
Q3 		$4.81M Sell
44,574
-821
-2% -$93.8K 0.42% 76
2021
Q2 		$5.11M Buy
45,395
+1,035
+2% +$117K 0.42% 77
2021
Q1 		$4.8M Sell
44,360
-1,904
-4% -$204K 0.42% 74
2020
Q4 		$4.96M Sell
46,264
-10,324
-18% -$992K 0.46% 74
2020
Q3 		$4.96M Sell
56,588
-626
-1% -$58.9K 0.46% 66
2020
Q2 		$5.62M Sell
57,214
-411
-0.7% -$36.2K 0.54% 50
2020
Q1 		$4.39M Buy
57,625
+324
+0.6% +$27.6K 0.5% 56
2019
Q4 		$5.07M Buy
57,301
+1,316
+2% +$109K 0.44% 72
2019
Q3 		$4.24M Buy
55,985
+206
+0.4% +$14.1K 0.39% 84
2019
Q2 		$4.06M Buy
55,779
+890
+2% +$70K 0.37% 87
2019
Q1 		$4.42M Buy
54,889
+9,690
+21% +$793K 0.42% 80
2018
Q4 		$4.17M Buy
45,199
+168
+0.4% +$14.8K 0.53% 73
2018
Q3 		$4.26M Buy
45,031
+145
+0.3% +$13.8K 0.48% 89
2018
Q2 		$4.16M Buy
44,886
+84
+0.2% +$8.2K 0.48% 87
2018
Q1 		$4.24M Sell
44,802
-34,504
-44% -$3.79M 0.51% 87
2017
Q4 		$7.67M Sell
79,306
-1,720
-2% -$162K 0.86% 32
2017
Q3 		$7.2M Sell
81,026
-1,061
-1% -$80.8K 0.85% 33
2017
Q2 		$5.95M Sell
82,087
-2,336
-3% -$157K 0.73% 42
2017
Q1 		$5.5M Sell
84,423
-1,064
-1% -$66.9K 0.69% 48
2016
Q4 		$5.35M Buy
85,487
+2,482
+3% +$152K 0.7% 46
2016
Q3 		$5.24M Sell
83,005
-718
-0.9% -$46.5K 0.71% 44
2016
Q2 		$5.18M Sell
83,723
-113
-0.1% -$6.88K 0.71% 43
2016
Q1 		$4.79M Buy
83,836
+2,241
+3% +$125K 0.68% 49
2015
Q4 		$4.83M Sell
81,595
-53,301
-40% -$3.07M 0.71% 49
2015
Q3 		$7.34M Sell
134,896
-922
-0.7% -$60K 1.16% 17
2015
Q2 		$9.13M Sell
135,818
-234
-0.2% -$15.3K 1.38% 6
2015
Q1 		$7.96M Sell
136,052
-4,115
-3% -$249K 1.2% 12
2014
Q4 		$9.17M Buy
140,167
+2,492
+2% +$157K 1.39% 5
2014
Q3 		$7.95M Sell
137,675
-272
-0.2% -$15.1K 1.32% 7
2014
Q2 		$7.79M Buy
137,947
+65,913
+92% +$3.46M 1.29% 6
2014
Q1 		$3.7M Buy
72,034
+2,509
+4% +$127K 0.66% 62
2013
Q4 		$3.67M Sell
69,525
-1,765
-2% -$86.7K 0.67% 65
2013
Q3 		$3.19M Sell
71,290
-67,410
-49% -$2.99M 0.65% 68
2013
Q2 		$5.73M Buy
+138,700
New +$6.07M 0.61% 77

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Goelzer Investment Management's ABBV Position: Q2 2026 in Review

Goelzer Investment Management reduced its AbbVie (ABBV) stake by 3.7% in Q2 2026, selling an estimated $512K and leaving 62,744 shares worth $15.8M. The position accounts for 0.69% of the portfolio, ranked #20.

Goelzer Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Goelzer Investment Management held 62,744 shares of AbbVie worth $15.8M as of Q2 2026.
  • Goelzer Investment Management sold 2,378 AbbVie shares in Q2 2026, an estimated $512K.
  • AbbVie made up 0.69% of Goelzer Investment Management's portfolio in Q2 2026, its #20 holding.
  • Goelzer Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Goelzer Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.